Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Vertex Pharmaceuticals (DE:VX1)
XETRA:VX1
RESEARCH TOOLSreports
Holding DE:VX1?
Track your performance easily
Vertex Pharmaceuticals (VX1) Ownership Overview
0.17% Insiders
35.14% Mutual Funds
0.79% Other Institutional Investors
23.86% ETFs
40.04% Public Companies and Individual Investors
The ownership structure of Vertex Pharmaceuticals (DE:VX1) stock is a mix of institutional, retail, and individual investors. Approximately 59.79% of the company’s stock is owned by Institutional Investors, 0.17% is owned by Insiders, and 40.04% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
| Sep 30, 2024 | xxxxxxxxxxxxx | $6976 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $515773 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $948763 | |
| Sep 30, 2024 | xxxxxxxxxxxxx | $1605456 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 20,618,488 | Institution | 8.01% | 8,778,444,977 | |
| 17,881,782 | Institution | 6.94% | 7,613,275,977 | |
| 12,682,165 | Institution | 4.92% | 5,399,507,842 | |
| 9,813,395 | Institution | 3.81% | 4,178,111,802 | |
| 8,442,467 | Institution | 3.28% | 3,594,430,980 | |
| 8,128,326 | Institution | 3.16% | 3,460,683,564 | |
| 5,253,155 | Institution | 2.04% | 2,236,562,260 | |
| 4,980,687 | Institution | 1.93% | 2,120,557,374 | |
| 4,345,688 | Institution | 1.69% | 1,850,202,740 | |
| 3,685,081 | Institution | 1.43% | 1,568,945,346 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 17,881,782 | Institution | 6.94% | 7,613,275,977 | |
| 8,128,326 | Institution | 3.16% | 3,460,683,564 | |
| 5,253,155 | Institution | 2.04% | 2,236,562,260 | |
| 4,980,687 | Institution | 1.93% | 2,120,557,374 | |
| 4,345,688 | Institution | 1.69% | 1,850,202,740 | |
| 3,685,081 | Institution | 1.43% | 1,568,945,346 | |
| 3,033,643 | Institution | 1.18% | 1,291,591,709 | |
| 2,936,678 | Institution | 1.14% | 1,250,308,279 | |
| 2,582,950 | Institution | 1.00% | 1,099,706,460 | |
| 2,463,087 | Institution | 0.96% | 1,048,674,069 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|
FAQ
Who Owns Vertex Pharmaceuticals (DE:VX1)?
According to the latest TipRanks data, approximately 0.79% of the company's stock is held by institutional investors, 0.17% is held by insiders, and 40.04% is held by retail investors.
What percentage of Vertex Pharmaceuticals (DE:VX1) stock is held by institutional investors?
According to the latest TipRanks data, approximately 0.79% of Vertex Pharmaceuticals (DE:VX1) stock is held by institutional investors.
What percentage of Vertex Pharmaceuticals (DE:VX1) stock is held by retail investors?
According to the latest TipRanks data, approximately 40.04% of Vertex Pharmaceuticals (DE:VX1) stock is held by retail investors.
Who owns the most shares of Vertex Pharmaceuticals (DE:VX1)?
Vanguard owns the most shares of Vertex Pharmaceuticals (DE:VX1).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.